Literature DB >> 9375867

Comparison of 3 quantitative measures of hand radiographs in patients with rheumatoid arthritis: Steinbrocker stage, Kaye modified Sharp score, and Larsen score.

T Pincus1, A Larsen, R H Brooks, J Kaye, E P Nance, L F Callahan.   

Abstract

OBJECTIVE: To compare 3 quantitative hand radiograph scores, Steinbrocker stage, Larsen score, and Sharp score modified by Kaye, to one another and to other measures of clinical status in a cross sectional analysis of hand radiographs of 173 patients with rheumatoid arthritis (RA).
METHODS: Radiographs were scored and compared to other measures of clinical status according to correlation and cross tabulation analyses.
RESULTS: In these cross sectional studies, radiographic scores according to all 3 methods were correlated at high levels (r(s) > 0.5) with one another and duration of disease, as well as with scores for physical joint deformity and limited motion; at lower levels (0.3 < r(s) < 0.5) with physical joint swelling scores, functional status, and age; and at low levels of marginal or no clinical importance (r(s) < 0.3) with physical joint tenderness scores, laboratory data, and pain scores.
CONCLUSION: The 3 scoring methods give similar quantitative information concerning hand radiographs of patients with RA. The Larsen and modified Sharp scores are preferred measures, as the detailed information facilitates comparison of different patients and monitoring of individual patients over time.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9375867

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Assessment of phalangeal bone loss in patients with rheumatoid arthritis by quantitative ultrasound.

Authors:  P Röben; R Barkmann; S Ullrich; A Gause; M Heller; C C Glüer
Journal:  Ann Rheum Dis       Date:  2001-07       Impact factor: 19.103

Review 2.  Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages.

Authors:  S Boini; F Guillemin
Journal:  Ann Rheum Dis       Date:  2001-09       Impact factor: 19.103

3.  Serum levels of anti-cyclic citrullinated peptide antibodies are associated with a beneficial response to traditional herbal medicine (Kampo) in rheumatoid arthritis.

Authors:  Toshiaki Kogure; Hiroko Sato; Daijiro Kishi; Tomoyuki Ito; Takeshi Tatsumi
Journal:  Rheumatol Int       Date:  2009-02-22       Impact factor: 2.631

4.  T cells, fibroblast-like synoviocytes, and granzyme B+ cytotoxic cells are associated with joint damage in patients with recent onset rheumatoid arthritis.

Authors:  M C Kraan; J J Haringman; H Weedon; E C Barg; M D Smith; M J Ahern; T J M Smeets; F C Breedveld; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

5.  Polymorphism in the tumor necrosis factor-alpha gene promoter is associated with severity of rheumatoid arthritis in the Czech population.

Authors:  Petr Nemec; Monika Pavkova-Goldbergova; Martina Stouracova; Anna Vasku; Miroslav Soucek; Jindra Gatterova
Journal:  Clin Rheumatol       Date:  2007-06-12       Impact factor: 2.980

6.  Abatacept: the evidence for its place in the treatment of rheumatoid arthritis.

Authors:  Marcus D Köller
Journal:  Core Evid       Date:  2008-02-29

7.  Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases.

Authors:  Matthew Traylor; Rachel Knevel; Jing Cui; John Taylor; Westra Harm-Jan; Philip G Conaghan; Andrew P Cope; Charles Curtis; Paul Emery; Stephen Newhouse; Hamel Patel; Sophia Steer; Peter Gregersen; Nancy A Shadick; Michael E Weinblatt; Annette Van Der Helm-van Mil; Jennifer H Barrett; Ann W Morgan; Cathryn M Lewis; Ian C Scott
Journal:  PLoS One       Date:  2019-10-09       Impact factor: 3.240

8.  Long-term persistence and effects of fetal microchimerisms on disease onset and status in a cohort of women with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  Marianne Kekow; Maria Barleben; Susanne Drynda; Sibylle Jakubiczka; Jörn Kekow; Thomas Brune
Journal:  BMC Musculoskelet Disord       Date:  2013-11-18       Impact factor: 2.362

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.